IC

Iowa Capital Management

North America, Iowa, United States, Fairfield

Description

Futures Investments

Investor Profile

Iowa Capital Management has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Genetics, Health Care.

Stage Focus

  • Series C (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Iowa Capital Management frequently co-invest with?

AS
North America, Iowa, United States, Ames
Co-Investments: 2
MO
North America, Iowa, United States, Ames
Co-Investments: 2
CI
North America, Illinois, United States, Chicago
Co-Investments: 1
Co-Investments: 2

What are some of recent deals done by Iowa Capital Management?

NewLink Genetics

Ames, Iowa, United States

NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.

BiotechnologyGeneticsHealth CareOncologyTherapeutics
Series CJan 31, 2008
Amount Raised: $17,000,000
NewLink Genetics

Ames, Iowa, United States

NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.

BiotechnologyGeneticsHealth CareOncologyTherapeutics
Series BSep 7, 2007
Amount Raised: $8,244,000

Find More Investors Like Iowa Capital Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Iowa Capital Management | Pipeseed